Gujarat Themis Biosyn Limited (BOM:506879)
India · Delayed Price · Currency is INR 404.10
-29.40 (-6.78%)
At close: May 29, 2026
Gujarat Themis Biosyn Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,658 | 1,508 | 1,698 | 1,484 | 1,149 | |
Revenue Growth (YoY) | 9.96% | -11.20% | 14.45% | 29.20% | 26.82% |
Cost of Revenue | 582.8 | 593.2 | 687.4 | 573.39 | 181.25 |
Gross Profit | 1,075 | 914.8 | 1,011 | 910.46 | 967.29 |
Selling, General & Admin | 176.99 | 137.35 | 128.68 | 89.42 | 71.99 |
Other Operating Expenses | 143.14 | 80.37 | 95.04 | 76.04 | 307.64 |
Operating Expenses | 449.32 | 271.47 | 259.08 | 191.22 | 401.96 |
Operating Income | 626.11 | 643.33 | 751.75 | 719.25 | 565.33 |
Interest Expense | -29.49 | -2.33 | -1.43 | -0.95 | -6.56 |
Interest & Investment Income | - | 7.12 | 40.35 | 51.29 | 32.61 |
Currency Exchange Gain (Loss) | - | 0.53 | 0.23 | - | 0.09 |
Other Non Operating Income (Expenses) | 24.28 | 6.73 | 2.45 | 5.06 | -1.13 |
EBT Excluding Unusual Items | 620.9 | 655.38 | 793.34 | 774.65 | 590.35 |
Pretax Income | 620.9 | 655.38 | 793.34 | 774.65 | 590.35 |
Income Tax Expense | 154.09 | 167.66 | 201.71 | 194.96 | 154.1 |
Net Income | 466.82 | 487.72 | 591.63 | 579.69 | 436.24 |
Net Income to Common | 466.82 | 487.72 | 591.63 | 579.69 | 436.24 |
Net Income Growth | -4.29% | -17.56% | 2.06% | 32.88% | 44.55% |
Shares Outstanding (Basic) | 109 | 109 | 109 | 109 | 109 |
Shares Outstanding (Diluted) | 109 | 109 | 109 | 109 | 109 |
Shares Change (YoY) | 0.10% | - | - | - | - |
EPS (Basic) | 4.28 | 4.48 | 5.43 | 5.32 | 4.00 |
EPS (Diluted) | 4.28 | 4.48 | 5.43 | 5.32 | 4.00 |
EPS Growth | -4.38% | -17.56% | 2.06% | 32.88% | 44.57% |
Free Cash Flow | -1,238 | -251.22 | -104.32 | 157.74 | 264.16 |
Free Cash Flow Per Share | -11.35 | -2.31 | -0.96 | 1.45 | 2.42 |
Dividend Per Share | 0.670 | 0.670 | 1.000 | 0.720 | 0.800 |
Dividend Growth | - | -33.00% | 38.89% | -10.00% | - |
Gross Margin | 64.85% | 60.66% | 59.52% | 61.36% | 84.22% |
Operating Margin | 37.76% | 42.66% | 44.27% | 48.47% | 49.22% |
Profit Margin | 28.15% | 32.34% | 34.84% | 39.07% | 37.98% |
Free Cash Flow Margin | -74.63% | -16.66% | -6.14% | 10.63% | 23.00% |
EBITDA | 755.3 | 684.61 | 775.58 | 737.48 | 580.14 |
EBITDA Margin | 45.55% | 45.40% | 45.67% | 49.70% | 50.51% |
D&A For EBITDA | 129.19 | 41.28 | 23.83 | 18.24 | 14.81 |
EBIT | 626.11 | 643.33 | 751.75 | 719.25 | 565.33 |
EBIT Margin | 37.76% | 42.66% | 44.27% | 48.47% | 49.22% |
Effective Tax Rate | 24.82% | 25.58% | 25.42% | 25.17% | 26.10% |
Revenue as Reported | 1,683 | 1,532 | 1,742 | 1,550 | 1,189 |
Advertising Expenses | - | 0.07 | 0.16 | - | - |